Pages that link to "Q73943124"

The following pages link to Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure (Q73943124):

Displaying 40 items.

• Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS (Q27025771) (← links)
• Current status of calcium channel blockers in patients with cardiovascular disease (Q33642495) (← links)
• The pharmacology of ion channels: with particular reference to voltage-gated Ca2+ channels (Q33709304) (← links)
• Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event (Q34254787) (← links)
• Do most antihypertensive agents have a sympatholytic action? (Q34317643) (← links)
• Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris (Q34566315) (← links)
• Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension (Q34991490) (← links)
• Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options (Q35170115) (← links)
• Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture (Q35376558) (← links)
• Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris. (Q35579973) (← links)
• The Use of Calcium Antagonists in the Therapy of Hypertension in the Elderly (Q35587336) (← links)
• Calcium antagonists and beta-blockers: impact on cardiovascular and cerebrovascular events (Q36105726) (← links)
• Calcium channel blockers and the kidney (Q36105734) (← links)
• Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function (Q36861180) (← links)
• A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS). (Q37047293) (← links)
• The autonomic nervous system and renal physiology (Q37164618) (← links)
• Amlodipine and valsartan as components of a rational and effective fixed-dose combination (Q37167534) (← links)
• Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation (Q37385343) (← links)
• Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection (Q37589608) (← links)
• Modulation of the QT interval duration in hypertension with antihypertensive treatment (Q38383090) (← links)
• Diltiazem reduces mortality and breakdown of ATP in red blood cell induced by isoproterenol in a freely moving rat model in vivo. (Q42939189) (← links)
• Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study (Q43252111) (← links)
• Less adrenergic response to mental task during verapamil compared to amlodipine treatment in hypertensive subjects (Q43684289) (← links)
• Radionuclide monitoring of left ventricular function after sublingual nifedipine administration at rest and during moderate physical activity (Q43810304) (← links)
• Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring (Q44105224) (← links)
• The effect of angiotensin II on the proliferation of human gingival fibroblasts. (Q45917093) (← links)
• Ventricular arrhythmia following short-acting nifedipine administration (Q46478392) (← links)
• Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects (Q46878274) (← links)
• Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone (Q57486832) (← links)
• The calcium antagonist controversy: a posthumous commentary 1 1Modified from Grossman E, Messerli FH. Calcium antagonists in cardiovascular disease: a necessary controversy but an unnecessary panic. (Editorial.) Am J Med 1997;102:147–149; and from (Q58855395) (← links)
• Differential Effect of β-Blockers for Heart Rate Control in Coronary Artery Disease (Q61671356) (← links)
• Energy-dependent accumulation of calcium antagonists in catecholamine storage vesicles (Q73791112) (← links)
• [Differentiation and evaluation of calcium antagonists in therapy of arterial hypertension] (Q73800179) (← links)
• Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study (Q74265775) (← links)
• Nisoldipine was associated with increased risk of MI among hypertensive diabetic patients when compared with enalapril (Q82093272) (← links)
• Effects of diltiazem on sympathetic activity in patients with aneurysmal subarachnoid hemorrhage (Q85902334) (← links)
• Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension (Q89733315) (← links)
• Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina (Q89846493) (← links)
• Effects of ischaemic conditioning on tissue oxygen saturation and heart rate variability: an observational study (Q92468874) (← links)
• Diltiazem hydrochloride: New technologies and evolution of diltiazem (Q94556574) (← links)